Tech Company Financing Transactions

Autobahn Therapeutics Funding Round

Autobahn Therapeutics, based in San Diego, received $76 million in funding from Arch Venture Partners, Cowen Capital Partners and Alexandria Venture Investments.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

9880 Campus Point Dr.
San Diego, CA 92121
USA

Phone

(858) 722-0037

Website

www.autobahntx.com

Email Address

[email protected]

Overview

Autobahn Therapeutics is focused on improving life health for people affected by CNS disorders by driving the regenerative power of the human body. Altering the progressive and debilitating course of these conditions by returning the brain to a healthier state will transcend the benefits offered by existing therapies and allow people to live the futures they deserve.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Kevin Finney

        

Chief Scientific Officer

Brian Stearns

        

President

Keith Lenden

        

Vice President

Chan Beals

        

Vice President

Deidre MacKenna

        

VP - Administration

John Borkholder

        

VP - Operations

Christine Maurer

        

Browse more venture capital transactions:

Prev: 6/9/2020: Clean Crop Technologies venture capital transaction
Next: 6/10/2020: Quini venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary